Charles Schwab’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-12,103
Closed -$189K 3675
2022
Q1
$189K Hold
12,103
﹤0.01% 3318
2021
Q4
$322K Hold
12,103
﹤0.01% 3271
2021
Q3
$591K Buy
12,103
+375
+3% +$23.2K ﹤0.01% 3088
2021
Q2
$989K Sell
11,728
-1,834
-14% -$158K ﹤0.01% 2937
2021
Q1
$1.37M Buy
13,562
+781
+6% +$85.8K ﹤0.01% 2753
2020
Q4
$1.29M Sell
12,781
-32
-0.2% -$2.14K ﹤0.01% 2705
2020
Q3
$593K Buy
12,813
+6,036
+89% +$310K ﹤0.01% 2831
2020
Q2
$391K Buy
+6,777
New +$452K ﹤0.01% 2929

Other funds holding AWH

Charles Schwab's AWH Position: Q2 2022 in Review

Charles Schwab sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q2 2022, closing a stake of 12,103 shares — an estimated $189K sold.

Charles Schwab first reported a position in AWH in Q2 2020 and held it in 8 quarters. The position peaked at $1.37M in Q1 2021. 72 funds tracked by Wall St. Rank hold AWH as of Q2 2022.

  • Charles Schwab reported no remaining Aspira Women's Health Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Charles Schwab sold 12,103 Aspira Women's Health Inc. Common Stock shares in Q2 2022, an estimated $189K.
  • Charles Schwab first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • Charles Schwab's Aspira Women's Health Inc. Common Stock position peaked at $1.37M in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q2 2022.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.